• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Nerve Sheath Neoplasms

Nerve Sheath Neoplasms - 21 Studies Found

Terminated : Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas
: Neurofibroma
: 2008-07-14
: Drug: LS11 LS11 will be given as a one-time IV infusion over 3-5 minutes.
Terminated : First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas
: Cutaneous Neurofibromas
: 2009-06-15
: Procedure: Erbium-YAG laser vaporization spot size 2-5 mm diameter, applying about 1,2 -2 J at a frequen
Active, not recruiting : Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas
:
  • Neurofibromatosis
  • Neurofibromas

: 2010-06-08
: Drug: Gleevec Gleevec will be dosed orally with a starting dose of 100 mg twice daily for patients with
Active, not recruiting : Study of PEG-Intron for Plexiform Neurofibromas
: Plexiform Neurofibroma
: 2006-11-02
: Drug: PEG-Intron
Completed : Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas
: Plexiform Neurofibromas
: 2014-06-25
: Drug: Imatinib Mesylate oral administration Other Na
Terminated : Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)
: Plexiform Neurofibroma Associated With Neurofibromatosis Type 1
: 2011-05-27
: Drug: Everolimus (RAD001) oral daily dosing of tablet starting with 2.5 mg
Completed : Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
:
  • Neurofibromatosis Type 1
  • Cutaneous Neurofibromas

: 2008-03-27
: Drug: Ranibizumab Given as an injection into three cutaneous neurofibromas on day 1 of the study treatme
Completed : Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
:
  • Neurofibromas
  • Neurofibromatosis Type 1

: 2006-04-11
Completed : Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
:
  • Neurofibromatosis Type 1
  • Cutaneous Neurofibromas

: 2009-03-17
: Drug: Imiquimod 5% Cream Applied topically to three tumors 5 times per week for a full 6 weeks
Active, not recruiting : Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1
:
  • Neurofibromatosis 1
  • Cutaneous Neurofibroma

: 2017-03-08
:
  • Drug: Diclofenac Sodium Follow

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.